Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 333

1.

Quality assurance in gastrointestinal endoscopy: An Egyptian experience.

Gado AS, Ebeid BA, Axon AT.

Arab J Gastroenterol. 2016 Dec;17(4):153-158. doi: 10.1016/j.ajg.2016.11.002. Epub 2016 Dec 15. Review.

PMID:
27988235
2.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel.

Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

PMID:
27707777
3.

Helicobacter pylori and Nonmalignant Diseases.

Potamitis GS, Axon AT.

Helicobacter. 2015 Sep;20 Suppl 1:26-9. doi: 10.1111/hel.12253. Review.

PMID:
26372821
4.

Guidelines for designing a digestive disease endoscopy unit: report of the World Endoscopy Organization.

Mulder CJ, Jacobs MA, Leicester RJ, Nageshwar Reddy D, Shepherd LE, Axon AT, Waye JD.

Dig Endosc. 2013 Jul;25(4):365-75. doi: 10.1111/den.12126. Epub 2013 May 22. Review.

PMID:
23701732
5.

The natural history of gastro-oesophageal reflux symptoms in the community and its effects on survival: a longitudinal 10-year follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Aliment Pharmacol Ther. 2013 Feb;37(3):323-31. doi: 10.1111/apt.12169. Epub 2012 Nov 29.

6.

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ; European Helicobacter Study Group.

Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.

PMID:
22491499
7.

Effect of dyspepsia on survival: a longitudinal 10-year follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Am J Gastroenterol. 2012 Jun;107(6):912-21. doi: 10.1038/ajg.2012.69. Epub 2012 Apr 3.

PMID:
22472745
8.

Clinical outcome of acute upper gastrointestinal hemorrhage among patients admitted to a government hospital in Egypt.

Gado AS, Ebeid BA, Abdelmohsen AM, Axon AT.

Saudi J Gastroenterol. 2012 Jan-Feb;18(1):34-9. doi: 10.4103/1319-3767.91737.

9.

Prevalence of microscopic colitis in patients with chronic diarrhea in Egypt: a single-center study.

Gado AS, Ebeid BA, El Hindawi AA, Akl MM, Axon AT.

Saudi J Gastroenterol. 2011 Nov-Dec;17(6):383-6. doi: 10.4103/1319-3767.87178.

10.

Review article: methods of measuring gastric acid secretion.

Ghosh T, Lewis DI, Axon AT, Everett SM.

Aliment Pharmacol Ther. 2011 Apr;33(7):768-81. doi: 10.1111/j.1365-2036.2010.04573.x. Epub 2011 Jan 24. Review.

11.

Epidemiology of Helicobacter pylori infection and public health implications.

Ford AC, Axon AT.

Helicobacter. 2010 Sep;15 Suppl 1:1-6. doi: 10.1111/j.1523-5378.2010.00779.x. Review.

PMID:
21054646
12.

A study of indefinite for dysplasia in Barrett's oesophagus: reproducibility of diagnosis, clinical outcomes and predicting progression with AMACR (alpha-methylacyl-CoA-racemase).

Sonwalkar SA, Rotimi O, Scott N, Verghese E, Dixon M, Axon AT, Everett SM.

Histopathology. 2010 Jun;56(7):900-7. doi: 10.1111/j.1365-2559.2010.03571.x.

PMID:
20636793
13.

Sedation in digestive endoscopy: the Athens international position statements.

Cohen LB, Ladas SD, Vargo JJ, Paspatis GA, Bjorkman DJ, Van der Linden P, Axon AT, Axon AE, Bamias G, Despott E, Dinis-Ribeiro M, Fassoulaki A, Hofmann N, Karagiannis JA, Karamanolis D, Maurer W, O'Connor A, Paraskeva K, Schreiber F, Triantafyllou K, Viazis N, Vlachogiannakos J.

Aliment Pharmacol Ther. 2010 Aug;32(3):425-42. doi: 10.1111/j.1365-2036.2010.04352.x. Epub 2010 May 8.

14.

Throat spray, sedation or anaesthetic?

Axon AT.

Digestion. 2010;82(2):77-9. doi: 10.1159/000285337. Epub 2010 Apr 21.

15.

Quality assurance and credentialing in endoscopy: the standard of care for the future?

Axon AT.

Endoscopy. 2009 Dec;41(12):1078-9. doi: 10.1055/s-0029-1215357. Epub 2009 Dec 4. No abstract available.

PMID:
19967623
16.

The Calcium Carbonate Breath Test, a noninvasive test of stimulated gastric acid secretion: preliminary communication.

Clough MR, Axon AT.

Eur J Gastroenterol Hepatol. 2009 Mar;21(3):266-72. doi: 10.1097/MEG.0b013e328321837e.

PMID:
19279471
17.

The pathogenesis of colorectal cancer. Foreword.

Axon AT.

Gastrointest Endosc. 2008 Oct;68(4 Suppl):S2. doi: 10.1016/j.gie.2008.09.004. No abstract available.

PMID:
18805237
18.

Fluctuation of gastrointestinal symptoms in the community: a 10-year longitudinal follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Aliment Pharmacol Ther. 2008 Oct 15;28(8):1013-20. doi: 10.1111/j.1365-2036.2008.03813.x. Epub 2008 Jul 24.

19.

Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Am J Gastroenterol. 2008 May;103(5):1229-39; quiz 1240. doi: 10.1111/j.1572-0241.2007.01740.x. Epub 2008 Mar 26.

PMID:
18371141
20.
21.

Clinical trial: knowledge of negative Helicobacter pylori status reduces subsequent dyspepsia-related resource use.

Ford AC, Forman D, Nathan J, Crocombe WD, Axon AT, Moayyedi P.

Aliment Pharmacol Ther. 2007 Nov 1;26(9):1267-75.

22.

Mycophenolate mofetil therapy for refractory inflammatory bowel disease.

Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ.

Inflamm Bowel Dis. 2007 Dec;13(12):1488-92.

PMID:
17924566
23.

Effect of sibling number in the household and birth order on prevalence of Helicobacter pylori: a cross-sectional study.

Ford AC, Forman D, Bailey AG, Goodman KJ, Axon AT, Moayyedi P.

Int J Epidemiol. 2007 Dec;36(6):1327-33. Epub 2007 Sep 28.

PMID:
17905807
24.

Low-grade dysplasia in Barrett's esophagus has a high risk of progression.

Lim CH, Treanor D, Dixon MF, Axon AT.

Endoscopy. 2007 Jul;39(7):581-7.

PMID:
17611911
25.

Who consults with dyspepsia? Results from a longitudinal 10-yr follow-up study.

Ford AC, Forman D, Bailey AG, Cook MB, Axon AT, Moayyedi P.

Am J Gastroenterol. 2007 May;102(5):957-65. Epub 2007 Feb 21.

PMID:
17313501
26.

Initial poor quality of life and new onset of dyspepsia: results from a longitudinal 10-year follow-up study.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Gut. 2007 Mar;56(3):321-7. Epub 2006 Aug 14.

27.
28.

A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial.

Ford AC, Forman D, Bailey AG, Axon AT, Moayyedi P.

Gastroenterology. 2005 Dec;129(6):1910-7.

PMID:
16344059
29.

Review article: gastro-oesophageal reflux disease--the extent of the problem.

Moayyedi P, Axon AT.

Aliment Pharmacol Ther. 2005 Aug;22 Suppl 1:11-9. Review.

30.

Gastro-oesophageal reflux is more prevalent in Western dyspeptics: a prospective comparison of British and South-East Asian patients with dyspepsia.

Mahadeva S, Raman MC, Ford AC, Follows M, Axon AT, Goh KL, Moayyedi P.

Aliment Pharmacol Ther. 2005 Jun 15;21(12):1483-90.

31.

Cost-effectiveness and long-term impact of Helicobacter pylori 'test and treat' service in reducing open access endoscopy referrals.

Sreedharan A, Clough M, Hemingbrough E, Gatta L, Chalmers DM, Axon AT, Moayyedi P.

Eur J Gastroenterol Hepatol. 2004 Oct;16(10):981-6.

PMID:
15371920
32.

Legal and Ethical Considerations: Group 4 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003.

Axon AT, Beilenhoff U, James T, Ladas SD, Larsen E, Neumann CS, Nowak A, Schöfl R, Tveit KM.

Endoscopy. 2004 Apr;36(4):362-5. No abstract available.

PMID:
15057692
34.

Setting up a quality assurance program in endoscopy.

Naylor G, Gatta L, Butler A, Duffet S, Wilcox M, Axon AT, O'Mahony S.

Endoscopy. 2003 Aug;35(8):701-7. Review.

PMID:
12929070
35.

ESGE/ESGENA Guideline for Live Demonstration Courses.

Kruse A, Beilenhoff U, Axon AT; European Society of Gastrointestinal Endoscopy; European Society of Gastrointestinal Endoscopy Nurses and Associates.

Endoscopy. 2003 Sep;35(9):781-4. No abstract available.

PMID:
12929031
36.

Recommendations of the ESGE workshop on Ethics in Teaching and Learning Endoscopy. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003.

Axon AT, Aabakken L, Malfertheiner P, Danielides I, Ladas S, Hochberger J, Williams C, Campbell D, Zakaria MS.

Endoscopy. 2003 Sep;35(9):761-4. No abstract available.

PMID:
12929025
37.

Low-grade dysplasia: nonsurgical treatment.

Lim CH, Axon AT.

Inflamm Bowel Dis. 2003 Jul;9(4):270-2; discussion 273-5. No abstract available.

PMID:
12902851
38.

Ten year follow up of ulcerative colitis patients with and without low grade dysplasia.

Lim CH, Dixon MF, Vail A, Forman D, Lynch DA, Axon AT.

Gut. 2003 Aug;52(8):1127-32.

39.

Mycophenolate mofetil in refractory inflammatory bowel disease.

Ford AC, Towler RJ, Moayyedi P, Chalmers DM, Axon AT.

Aliment Pharmacol Ther. 2003 Jun 1;17(11):1365-9.

40.

The effect of Helicobacter pylori infection on levels of DNA damage in gastric epithelial cells.

Everett SM, White KL, Drake IM, Schorah CJ, Calvert RJ, Skinner C, Stringer MD, Miller D, Dixon MF, Chalmers DM, Axon AT.

Helicobacter. 2002 Oct;7(5):271-80.

PMID:
12390206
41.

Bile reflux gastritis and intestinal metaplasia at the cardia.

Dixon MF, Mapstone NP, Neville PM, Moayyedi P, Axon AT.

Gut. 2002 Sep;51(3):351-5.

42.

Relation of adult lifestyle and socioeconomic factors to the prevalence of Helicobacter pylori infection.

Moayyedi P, Axon AT, Feltbower R, Duffett S, Crocombe W, Braunholtz D, Richards ID, Dowell AC, Forman D; Leeds HELP Study Group.

Int J Epidemiol. 2002 Jun;31(3):624-31.

PMID:
12055165
43.

Symposium: Helicobacter pylori and clinical risks--focus on gastro-oesophageal reflux disease.

Malfertheiner P, O'Connor HJ, Genta RM, Unge P, Axon AT.

Aliment Pharmacol Ther. 2002 Jun;16 Suppl 3:1-10.

44.

Antioxidant vitamin supplements do not reduce reactive oxygen species activity in Helicobacter pylori gastritis in the short term.

Everett SM, Drake IM, White KL, Mapstone NP, Chalmers DM, Schorah CJ, Axon AT.

Br J Nutr. 2002 Jan;87(1):3-11.

PMID:
11898768
45.

The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.

Mason J, Axon AT, Forman D, Duffett S, Drummond M, Crocombe W, Feltbower R, Mason S, Brown J, Moayyedi P; Leeds HELP Study Group.

Aliment Pharmacol Ther. 2002 Mar;16(3):559-68.

46.

ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa.

Yoshimura T, Tomita T, Dixon MF, Axon AT, Robinson PA, Crabtree JE.

J Infect Dis. 2002 Feb 1;185(3):332-40. Epub 2002 Jan 17.

PMID:
11807715
47.

Variant Creutzfeldt-Jakob disease (vCJD) and gastrointestinal endoscopy.

Axon AT, Beilenhoff U, Bramble MG, Ghosh S, Kruse A, McDonnell GE, Neumann C, Rey JF, Spencer K; Guidelines Committee. European Society of Gastrointestinal Endoscopy (ESGE).

Endoscopy. 2001 Dec;33(12):1070-80. Review.

PMID:
11740649
48.

Early diagnosis and prevention of sporadic colorectal cancer.

Lambert R, Provenzale D, Ectors N, Vainio H, Dixon MF, Atkin W, Werner M, Franceschi S, Watanabe H, Tytgat GN, Axon AT, Neuhaus H.

Endoscopy. 2001 Dec;33(12):1042-64. Review. No abstract available.

PMID:
11740647
49.

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease.

Moayyedi P, Bardhan C, Young L, Dixon MF, Brown L, Axon AT.

Gastroenterology. 2001 Nov;121(5):1120-6.

PMID:
11677204
50.

Bile reflux gastritis and Barrett's oesophagus: further evidence of a role for duodenogastro-oesophageal reflux?

Dixon MF, Neville PM, Mapstone NP, Moayyedi P, Axon AT.

Gut. 2001 Sep;49(3):359-63.

Supplemental Content

Support Center